Amsterdam-based Lapsi Health, a health tech startup, announced on Tuesday, January 10, that it has raised $3.5M (approximately €3.25M) in an oversubscribed Seed round of funding. The Dutch startup is developing sound-based medical technology and software tools to empower clinicians at the point of care and to enhance remote consultations.
The company’s previous funding came at the beginning of last year when it received a €700K pre-Seed round in March 2022, and also won a €1M Eurostars grant for the advancement of its deep technology.
Lapsi Health says that the new funds will be utilised to continue its technology development, get FDA approval, and begin commercialisation activities in the US.
Investors supporting Lapsi Health
The round was led by Sahir Ali of Modi Ventures, a Texas-based family office that has recently stepped into the Venture Capital world with investments in Artificial intelligence and Tech Bio.
The investment also saw participation from existing investors Vendash and Bolwork, as well as new investor BeKey, an Israeli-Ukrainian software development company.
Jhonatan Bringas Dimitriades, CEO at Lapsi Health, says, “During the year we released 4 generations of prototypes and two native applications. We have been able to validate our technology and showcase it in several venues worldwide and to several medical leaders. This helped us to secure the next step in the funding for our company, now with the goal of bringing our technology to the market during 2023.”
“Redefining Sound in Medicine”
Lapsi Health was founded in 2021 by Jhonatan Bringas Dimitriades, Diana van Stijn, Seamus Holohan, and Rodrigo Alvez. It is a medical technology development company that aims to change how auscultatory sounds are currently used in the fields of medicine and pharma-biotech.
The medical definition of auscultation is listening to the sounds of your heart, lungs, arteries, and belly (abdomen). Lapsi Health’s products are built for doctors, patients and researchers.
Chief Medical Officer and co-founder Diana van Stijn says, “Data-driven decisions are the next step to improving healthcare, patient empowerment, clinical intelligence and to make clinical research more democratised. These are the ideals that inspired us to create Lapsi Health.”
In the last 10 months, the company has grown from 4 to more than 10 employees (including their Head of Engineering, Toni Leinonen, founder of Haltian and former lead within the team that developed the Oura Ring) and 8 advisors.
The company’s Advisory Board includes several World healthcare leaders such as Craig Lipset, Rafael Grossman, Aline Noizet, Suzanne Terheggen, Carlos Sendon, and Amir Lahav.
Advisory Board Member and co-Chair of the DTRA, Craig Lipset, says, “As a patient, all of my encounters with my primary care provider and my pulmonologist involve listening to my lungs. Lapsi Health brings that capability with confidence for remote care as well as remote clinical trials. The technology will improve patient experience and outcomes while supporting the new normal for healthcare and clinical research.”
In the last quarter of 2022, the company welcomed Junaid Bajwa, MD, Chief Medical Scientist at Microsoft, as a new member of the advisory board. “With his vast med-tech experience, we will be able to develop and iterate even faster,” says co-founder Dimitriades.
01
Tech meets private credit: Demystifying Norsad Capital’s efficiency boost with PE Front Office